Sanctuary Advisors LLC Grows Stake in Corteva, Inc. $CTVA

Sanctuary Advisors LLC increased its position in shares of Corteva, Inc. (NYSE:CTVA) by 8.4% in the 1st quarter, HoldingsChannel.com reports. The firm owned 83,529 shares of the company’s stock after acquiring an additional 6,454 shares during the period. Sanctuary Advisors LLC’s holdings in Corteva were worth $6,992,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of CTVA. JPL Wealth Management LLC purchased a new position in shares of Corteva in the third quarter valued at $25,000. Westfuller Advisors LLC boosted its position in shares of Corteva by 2,764.3% in the 1st quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after buying an additional 387 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of Corteva in the 4th quarter worth about $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva in the 4th quarter valued at about $28,000. Finally, Cornerstone Financial Management LLC acquired a new stake in Corteva in the 4th quarter valued at about $29,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Price Performance

Corteva stock opened at $87.42 on Friday. The stock has a market capitalization of $58.47 billion, a P/E ratio of 51.43, a P/E/G ratio of 2.67 and a beta of 0.56. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $88.22. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The firm’s 50-day moving average is $80.86 and its two-hundred day moving average is $78.19.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s payout ratio is presently 42.35%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of a number of research reports. Wells Fargo & Company lifted their target price on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Oppenheimer lifted their price objective on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Morgan Stanley upped their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. Finally, Jefferies Financial Group raised their price target on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $88.95.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.